ArticleJournal of thoracic disease2018

miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor.

Wei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.